Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term study of VAH631 in essential hypertension (extension from B1303)
jRCT2080220261Phase 3
- Sponsor
- Novartis
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sacubitril/valsartan + amlodipine in essential hypertension, sponsored by Novartis.
02
Drugs
sacubitril/valsartan + amlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on jRCT2080220261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220261.